BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21876460)

  • 1. Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma.
    Wang W; Edington HD; Jukic DM; Rao UN; Land SR; Kirkwood JM
    Cancer Immunol Immunother; 2008 Sep; 57(9):1315-21. PubMed ID: 18386001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-VISTA Immunohistochemistry Score Is Associated with Advanced Stages in Cutaneous and Ocular Melanoma.
    Tinca AC; Szoke AR; Lazar BA; Szász EA; Tomuț AN; Sabău AH; Cocuz IG; Cotoi TC; Niculescu R; Chiorean DM; Ungureanu IA; Turdean SG; Cotoi OS
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis.
    Ekelund E; Saaf A; Tengvall-Linder M; Melen E; Link J; Barker J; Reynolds NJ; Meggitt SJ; Kere J; Wahlgren CF; Pershagen G; Wickman M; Nordenskjold M; Kockum I; Bradley M
    Am J Hum Genet; 2006 Jun; 78(6):1060-5. PubMed ID: 16685656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of protein disulphide isomerase A3 and phosphorylated signal transducer and activator of transcription 3 in cervical carcinoma.
    Abdullatif A; Abdelrahman AE; Bakry A; Gharieb SA; Ramadan MS; Wasfy MA; Abdelwanis AH; Fouad EM
    Contemp Oncol (Pozn); 2024; 28(1):51-62. PubMed ID: 38800530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel functional proteins coded by the human genome discovered in metastases of melanoma patients.
    Sanchez A; Kuras M; Murillo JR; Pla I; Pawlowski K; Szasz AM; Gil J; Nogueira FCS; Perez-Riverol Y; Eriksson J; Appelqvist R; Miliotis T; Kim Y; Baldetorp B; Ingvar C; Olsson H; Lundgren L; Ekedahl H; Horvatovich P; Sugihara Y; Welinder C; Wieslander E; Kwon HJ; Domont GB; Malm J; Rezeli M; Betancourt LH; Marko-Varga G
    Cell Biol Toxicol; 2020 Jun; 36(3):261-272. PubMed ID: 31599373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression.
    Tengesdal IW; Dinarello A; Powers NE; Burchill MA; Joosten LAB; Marchetti C; Dinarello CA
    Front Immunol; 2021; 12():661323. PubMed ID: 34531850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
    Liang C; Xu Y; Ge H; Li G; Wu J
    Onco Targets Ther; 2018; 11():1203-1214. PubMed ID: 29551899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
    Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
    Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2.
    Xuan X; Li S; Lou X; Zheng X; Li Y; Wang F; Gao Y; Zhang H; He H; Zeng Q
    Mol Biol Rep; 2015 May; 42(5):907-15. PubMed ID: 25407307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.
    Ohanna M; Cheli Y; Bonet C; Bonazzi VF; Allegra M; Giuliano S; Bille K; Bahadoran P; Giacchero D; Lacour JP; Boyle GM; Hayward NF; Bertolotto C; Ballotti R
    Oncotarget; 2013 Dec; 4(12):2212-24. PubMed ID: 24344100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma.
    Wu WY; Li J; Wu ZS; Zhang CL; Meng XL; Lobie PE
    Exp Ther Med; 2011 Jul; 2(4):647-653. PubMed ID: 22977555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis.
    Rottenberg ME; Carow B
    Semin Immunol; 2014 Dec; 26(6):518-32. PubMed ID: 25458989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
    Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
    Wu ZS; Cheng XW; Wang XN; Song NJ
    Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
    Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
    Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy.
    Wang W; Edington HD; Rao UN; Jukic DM; Wang H; Shipe-Spotloe JM; Kirkwood JM
    J Invest Dermatol; 2008 Aug; 128(8):1997-2002. PubMed ID: 18305569
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.